Cargando…
China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year
The China's top 10 hematological advances in 2021 was announced at the 2(nd) Annual Meeting of Chinese Alliance for Societies of Hematology on January 16, 2022.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974939/ https://www.ncbi.nlm.nih.gov/pubmed/35399542 http://dx.doi.org/10.1097/BS9.0000000000000103 |
| _version_ | 1784680305376886784 |
|---|---|
| author | Wang, Xiaochen |
| author_facet | Wang, Xiaochen |
| author_sort | Wang, Xiaochen |
| collection | PubMed |
| description | The China's top 10 hematological advances in 2021 was announced at the 2(nd) Annual Meeting of Chinese Alliance for Societies of Hematology on January 16, 2022. |
| format | Online Article Text |
| id | pubmed-8974939 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89749392022-04-07 China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year Wang, Xiaochen Blood Sci Editorial The China's top 10 hematological advances in 2021 was announced at the 2(nd) Annual Meeting of Chinese Alliance for Societies of Hematology on January 16, 2022. Lippincott Williams & Wilkins 2022-01-25 /pmc/articles/PMC8974939/ /pubmed/35399542 http://dx.doi.org/10.1097/BS9.0000000000000103 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the Chinese Medical Association (CMA) and Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College (IHCAMS). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Editorial Wang, Xiaochen China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year |
| title | China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year |
| title_full | China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year |
| title_fullStr | China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year |
| title_full_unstemmed | China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year |
| title_short | China's top 10 hematological advances in 2021 lists the key developments in hematology in China for that year |
| title_sort | china's top 10 hematological advances in 2021 lists the key developments in hematology in china for that year |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974939/ https://www.ncbi.nlm.nih.gov/pubmed/35399542 http://dx.doi.org/10.1097/BS9.0000000000000103 |
| work_keys_str_mv | AT wangxiaochen chinastop10hematologicaladvancesin2021liststhekeydevelopmentsinhematologyinchinaforthatyear |